Tyra Biosciences to Participate in Upcoming Investor Conferences
The company will hold one-on-one meetings in Boston and a hybrid presentation in London as it promotes its FGFR-focused pipeline.
- On Thursday, November 5, 2026, Resideo Technologies and Tyra Biosciences announced participation in upcoming investor conferences scheduled throughout November and December to engage with the financial community.
- Starting November 11, Resideo will participate in the Baird 2026 Global Industrial Conference in Chicago, followed by the Bank of America Leveraged Finance Conference and Wells Fargo's 10th Annual TMT Summit.
- Tyra is set to participate in the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 10, with a hybrid presentation at the Jefferies Global Healthcare Conference in London on November 16.
- Company executives, including Resideo CEO Tom Surran and CFO Shane Harrison, will conduct fireside chats and investor meetings, with webcasts available for replay for 30 days following each event.
- While Resideo supports more than 150 million residential and commercial spaces with control solutions, Tyra focuses on developing precision medicines targeting large opportunities in Fibroblast Growth Factor Receptor biology.
15 Articles
15 Articles
Tyra Biosciences to Participate in Upcoming Investor Conferences
CARLSBAD, Calif., Nov. 5, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced participation at the following investor…
Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences
ALAMEDA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics” or “the Company”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention,…
The Trinity Journal
Resideo To Participate at Upcoming Investor Conferences
SCOTTSDALE, Ariz., Nov. 4, 2026 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI), a leading developer and manufacturer of critical control and sensing solutions for residential end markets, today announced that it is scheduled to participate in the following investor events:
Cambridge Times
Alamar Biosciences to Participate in Upcoming Investor Conferences
Fremont, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced the company will be participating in the following investor conferences:
Tyra Biosciences to Participate in Upcoming Investor Conferences - PressReach
CARLSBAD, Calif., Nov. 5, 2026 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced participation at the following investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference 2026Format: One-on-one investor meetingsDate/Time: Novembe…
Coverage Details
Bias Distribution
- 55% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
